Related references
Note: Only part of the references are listed.Proteoglycan neofunctions: regulation of inflammation and autophagy in cancer biology
Liliana Schaefer et al.
FEBS JOURNAL (2017)
Decorin as a multivalent therapeutic agent against cancer
Thomas Neill et al.
ADVANCED DRUG DELIVERY REVIEWS (2016)
Decorin interacting network: A comprehensive analysis of decorin-binding partners and their versatile functions
Maria A. Gubbiotti et al.
MATRIX BIOLOGY (2016)
Soluble PD-L1: A biomarker to predict progression of autologous transplantation in patients with multiple myeloma
Shang-Yi Huang et al.
ONCOTARGET (2016)
Decoding the Matrix: Instructive Roles of Proteoglycan Receptors
Thomas Neill et al.
BIOCHEMISTRY (2015)
MET/HGF pathway in multiple myeloma: from diagnosis to targeted therapy?
Manuela Gambella et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2015)
Role of Decorin in Multiple Myeloma (MM) Bone Marrow Microenvironment
Neeharika Nemani et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2015)
Proteoglycan form and function: A comprehensive nomenclature of proteoglycans
Renato V. Iozzo et al.
MATRIX BIOLOGY (2015)
Decorin: A Growth Factor Antagonist for Tumor Growth Inhibition
Tero A. H. Jarvinen et al.
BIOMED RESEARCH INTERNATIONAL (2015)
MET dysregulation is a hallmark of aggressive disease in multiple myeloma patients
Alberto Rocci et al.
BRITISH JOURNAL OF HAEMATOLOGY (2014)
A HGF/cMET Autocrine Loop Is Operative in Multiple Myeloma Bone Marrow Endothelial Cells and May Represent a Novel Therapeutic Target
Arianna Ferrucci et al.
CLINICAL CANCER RESEARCH (2014)
Decorin Induces Mitophagy in Breast Carcinoma Cells via Peroxisome Proliferator- activated Receptor γ Coactivator-1α ( PGC-1 α) and Mitostatin*
Thomas Neill et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Decorin deficiency promotes hepatic carcinogenesis
Zsolt Horvath et al.
MATRIX BIOLOGY (2014)
Decorin is down-regulated in multiple myeloma and MGUS bone marrow plasma and inhibits HGF-induced myeloma plasma cell viability and migration
Ida B. Kristensen et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2013)
Decorin A Guardian from the Matrix
Thomas Neill et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
Small leucine-rich proteoglycans orchestrate receptor crosstalk during inflammation
Kristin Moreth et al.
CELL CYCLE (2012)
Immunohistochemical analysis of hepatocyte growth factor and c-Met in plasma cell disease
Karin F. Wader et al.
HISTOPATHOLOGY (2012)
Decorin Antagonizes the Angiogenic Network CONCURRENT INHIBITION OF MET, HYPOXIA INDUCIBLE FACTOR 1α, VASCULAR ENDOTHELIAL GROWTH FACTOR A, AND INDUCTION OF THROMBOSPONDIN-1 AND TIMP3
Thomas Neill et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Decorin Protein Core Affects the Global Gene Expression Profile of the Tumor Microenvironment in a Triple-Negative Orthotopic Breast Carcinoma Xenograft Model
Simone Buraschi et al.
PLOS ONE (2012)
Consensus recommendations for the uniform reporting of clinical trials: report of the International Myeloma Workshop Consensus Panel 1
S. Vincent Rajkumar et al.
BLOOD (2011)
MEDICAL PROGRESS Multiple Myeloma
Antonio Palumbo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Signaling by the Matrix Proteoglycan Decorin Controls Inflammation and Cancer Through PDCD4 and MicroRNA-21
Rosetta Merline et al.
SCIENCE SIGNALING (2011)
Multiple myeloma: changes in serum C-terminal telopeptide of collagen type I and bone-specific alkaline phosphatase can be used in daily practice to detect imminent osteolysis*
Thomas Lund et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2010)
Decorin Antagonizes Met Receptor Activity and Down-regulates β-Catenin and Myc Levels
Simone Buraschi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Decorin is a novel antagonistic ligand of the Met receptor
Silvia Goldoni et al.
JOURNAL OF CELL BIOLOGY (2009)
Role of decorin in the antimyeloma effects of osteoblasts
Xin Li et al.
BLOOD (2008)
Genetic deficiency of decorin causes intestinal tumor formation through disruption of intestinal cell maturation
Xiuli Bi et al.
CARCINOGENESIS (2008)
Expression of decorin, a small leucine-rich proteoglycan, as a prognostic factor in soft tissue tumors
Akihiko Matsumine et al.
JOURNAL OF SURGICAL ONCOLOGY (2007)
International uniform response criteria for multiple myeloma
B. G. M. Durie et al.
LEUKEMIA (2006)
Expression profiling correlates with treatment response in women with advanced serous epithelial ovarian cancer
Tanya R. Newton et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Nonirradiated NOD/SCID-human chimeric animal model for primary human multiple myeloma -: A potential in vivo culture system
SY Huang et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Pancreatic tumor cells influence the composition of the extracellular matrix
J Köninger et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Crystal structure of the dimeric protein core of decorin, the archetypal small leucine-rich repeat proteoglycan
PG Scott et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)